Affiliated Faculty

The Division of Nephrology at UCSF is proud to have a long history of multi-disciplinary collaboration. Our faculty and trainees work closely with many affiliated faculty who have active research interests related to nephrology. Many of these faculty members serve as mentors for nephrology fellows and junior faculty. Some of these include:

Selected affiiliated faculty in basic science and translational research

  • Wenhan Chang, PhD – role of extracellular calcium, insulin-like growth hormone-1, parathyroid hormone, and vitamin D and their respective receptors on mineral homeostasis, skeletal development, and fracture healing.
  • Markus Delling, PhD – molecular mechanisms of how primary cilia utilize ion channels and G-protein-coupled receptors to carry out important functions, which is important in autosomal dominant polycystic kidney disease.
  • Michael Grabe, PhD – biophysical properties of membranes and relationships between membrane lipids and transporters.
  • Lilly Jan, PhD – structure and function of potassium channels and their roles in development.
  • Keith Mostov, MD, PhD – epithelial development and repair, particularly of renal tubules, using cell culture, organoid, and animal models.
  • Jeremy Reiter, MD, PhD – cilia and ciliopathies, including polycystic kidney disease.
  • Shuvo Roy, PhD – leads the effort to develop the first implantable artificial kidney.
  • Julie Saba, MD, PhD – role of sphingosine phosphate-1 lyase in steroid-resistant nephrotic syndrome.
  • Dean Sheppard, MD – role of integrins in renal fibrosis.
  • Arthur Weiss, MD, PhD – T- and B-cell activation.

Selected affiliated faculty in clinical research:

  • Kirsten Bibbins-Domingo, MD, PhD, MAS – cardiovascular disease, diabetes, and chronic kidney disease with a particular interest in the development of chronic disease in young adults.
  • Edwin Charlebois, MPH, PhD PhD – epidemiology and prevention of HIV infection and its consequences. He has developed recent interest in chronic kidney disease in among HIV-infected individuals.
  • R. Adams Dudley, MD, MBA – developing measures of quality of care, assessing the impact of quality-based or value-based purchasing, and financial risk adjustment.
  • Neil Powe, MD, MPH, MBA – kidney disease patient-oriented research, clinical epidemiology and outcomes and effectiveness research.
  • Michael Shlipak, MD, MPH – causes and consequences of age-related kidney disease and utilizing novel biomarkers for the early detection of kidney damage and reduced kidney function.